Our Biomedical Science degree at @AstonUniversity is accredited by the IBMS. This is perfect if you're considering working as a HCPC Registered Biomedical Scientist. Have an offer from us? Come and hear about about the programme this Saturday.
aston.ac.uk/offer-holder-day…
🧬🥼| Aston University receives £10m grant from Research England to establish the Aston Institute for Membrane Excellence (AIME), a globally unique, cross-disciplinary institute to develop novel biomimetic membranes.
More info here! 👇
tinyurl.com/5n765rps
🏢| @AstonUniversity is to set up the Aston Institute for Membrane Excellence (AIME) after receiving £10m from @ResEngland
🧑🔬The globally unique institute will develop biomimetic membranes eg for water purification and drug development
👉tinyurl.com/5n765rps#TeamAston
🏢| @AstonUniversity is to set up the Aston Institute for Membrane Excellence (AIME) after receiving £10m from @ResEngland
🧑🔬The globally unique institute will develop biomimetic membranes eg for water purification and drug development
👉tinyurl.com/5n765rps#TeamAston
AIME will bring together researchers from a variety of disciplines to conduct ground breaking membrane research. Can't wait to further collaborations with @RoslynBill@alan_goddard@alice_rothnie@ProfDevitt@fredfercast83 Paul Topham and other amazing scientists!
Delighted that the Aston Institute for Membrane Excellence led by @RoslynBill has received E3 funding: it's a brilliant project which will has huge potential impact. Many congratulations to the team, including @CorinneSpickett@ProfDevitt, and to @AstonUniRKE for its support!
We're supporting 18 universities across England to expand their small, but outstanding research units with £156 million. This investment from the second round of our E3 fund will enable these units to build their research capacity. More: orlo.uk/mQHQE
ALT Dr Steven Hill, Director of Research at Research England, said:
We have invested in research units in universities right across England. This will diversify the regional spread of research disciplines to support the sustained enhancement of research capacity across England, and enhance the skills base, build and diversify talent and bring disciplines together to develop new skillsets and ‘future leaders’ in areas of research excellence where there is untapped potential.
Our investment will also help to reinforce the contribution of HEPs to their region through strategic local partnerships, focusing on sharing resources and infrastructure and generating local impact, backed by robust institutional leadership.
We’re excited to see how these units develop over the next five years.
We're supporting 18 universities across England to expand their small, but outstanding research units with £156 million. This investment from the second round of our E3 fund will enable these units to build their research capacity. More: orlo.uk/mQHQE
ALT Dr Steven Hill, Director of Research at Research England, said:
We have invested in research units in universities right across England. This will diversify the regional spread of research disciplines to support the sustained enhancement of research capacity across England, and enhance the skills base, build and diversify talent and bring disciplines together to develop new skillsets and ‘future leaders’ in areas of research excellence where there is untapped potential.
Our investment will also help to reinforce the contribution of HEPs to their region through strategic local partnerships, focusing on sharing resources and infrastructure and generating local impact, backed by robust institutional leadership.
We’re excited to see how these units develop over the next five years.
Come join the team and work with us as a Grants Officer! This is a permanent role for an aspiring research management professional to help us to continue to deliver our strategic plan. Closing date is 8th January 2024 and feel free to spread the word. Details can be found below:
Are you about to complete your PhD - or have recently completed it and are looking for an opportunity to use your skills to support other researchers? Why not check out this opportunity to join our team: tinyurl.com/yh8bfyn5
Congratulations @DiabetesUK on your research impact report and 85 years of progress! It is fantastic to see how research funded by our members is continuing to change many lives for the better.
Your donations have helped us achieve a lot in the last 85 years 💙 here are some of the highlights…
Check out our research impact report to see just how far we've come 👇🏾 orlo.uk/k9UKF#WDD23#StopDiabetesForever
🔬🥼Our Biomedical Science course gave Aleks the opportunity learn what she was passionate about
Find out more about her journey to Aston 👏
👇Watch the Full Video
🔗 youtube.com/watch?v=R59tSU4Z…
The entire academic board of the journal Neuroimage, including professors from Oxford University, King’s College London and Cardiff University resigned after Elsevier refused to reduce publication charges theguardian.com/science/2023…
See you there!! Don’t miss this one 😘. Repost from @wildgoatfestival
•
Come and have your G.O.A.T weekend! 🙌
Located at this stunning venue in the South Lakes for a festival like no other 🤩
Join us in the outdoors for an action packed weekend of ru… instagr.am/p/Crv_QuwtZVw/
ALT Quantum computing graphic which reads: Midlands Mindforge is a catalyst for boosting economic growth and creating highly-skilled jobs in the region
👨🔬 A route to synthetic antibodies (and their replacements)
Professor Anna Hine will start from the basics of molecular biology to explore this topic in her inaugural lecture on Tuesday 28th March.
Register: eventbrite.co.uk/e/an-inaugu…
🧬| Protein engineer to explore route from DNA blueprint to synthetic antibodies – public lecture
👥@AnnaVHine presents her inaugural public lecture
🗓 Tuesday 28 March 2023 @ 18.00
Sign up 👉bit.ly/3T6T5Fs
More info 👉bit.ly/3T2sbhX#TeamAston
A big shout out to @LVcares - I’ve been taking up them a fair amount recently and every single call has been superb. Quick answer and great service. Tonight I spoke to Chloe and I now wish I’d noted the names of all the others! Fab!
🧬| Our researchers are collaborating with biotechnology start-up @IsterianBio who are developing TG2 inhibitors to tackle fibrotic disease
🔬@AstonBioscience scientists are working at the preclinical stage to develop drugs to reverse lung disease
👉bit.ly/3XTh6RF